Kabakoff David S - 24 Jun 2021 Form 4 Insider Report for NextCure, Inc. (NXTC)

Role
Director
Signature
/s/ Steven P. Cobourn, as attorney-in fact for David S. Kabakoff
Issuer symbol
NXTC
Transactions as of
24 Jun 2021
Transactions value $
$0
Form type
4
Filing time
28 Jun 2021, 18:15:22 UTC
Previous filing
21 Jun 2021
Next filing
24 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NXTC Stock Option (Right to Buy) Award $0 +14.3K $0.00 14.3K 24 Jun 2021 Common Stock 14.3K $8.21 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in full on the earlier of June 24, 2022 and the date of the 2022 Annual Meeting of Stockholders.